Stocks and Investing
Stocks and Investing
Mon, January 8, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, January 5, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Michael Schmidt Downgraded (ALLO) to Hold on, Jan 5th, 2024
Michael Schmidt of Guggenheim, Downgraded "Allogene Therapeutics, Inc." (ALLO) to Hold on, Jan 5th, 2024.
Michael has made no other calls on ALLO in the last 4 months.
There are 3 other peers that have a rating on ALLO. Out of the 3 peers that are also analyzing ALLO, 0 agree with Michael's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Michael
- Samantha Semenkow of "Citigroup" Initiated at Strong Buy and Held Target at $7 on, Friday, December 8th, 2023
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $12 on, Wednesday, November 15th, 2023
- Brian Cheng of "JP Morgan" Maintained at Buy with Decreased Target to $9 on, Monday, September 25th, 2023
Contributing Sources